PATENT CLAIM ANALYSIS

Application Number: 15755618
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "048000"]

Abstract:
Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.

Claim (Index 14):
A method for the treatment of a tumor in a subject, comprising providing the crystal form II of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine-5\u2032-phosphate according to  claim 10  to the subject.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15760090', '15762895', '15328795', '15123378', '16098103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7698971137041015
- 35 USC 102 Novelty (BERT): 0.5001843902053543
- Combined Prediction Score: 0.7429258413542268
- Mean Citation Score: 231.988772
- Max Citation Score: 248.48439
- Similarity Product: 177.00498461817742

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test